Hype Hurts

The Chronicle of Higher Education features synthetic biology pioneer Jim Collins, who bemoans the fact that excessive hype has "hurt the field."

"Some in the community are hyping our capabilities well beyond where we're at," he says. "I think it's better to be a bit sober. I think it's fine to speak to emerging applications and emerging capabilities, but to really qualify where we are at and what we can do now, versus what might this field bring decades down the line."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.